康惠制药：赛乐仙协议转让599.28万股股份

Core Viewpoint - Shanghai Sailuxian Enterprise Management Consulting Co., Ltd. transferred a total of 5.9928 million shares of Kanghui Pharmaceutical at a price of 17.26 CNY per share, representing 6.00% of the total shares of the company, for a total consideration of 103 million CNY [1] Summary by Sections - The shareholding of Sailuxian before the transfer was 9.988 million shares, accounting for 10.00% of Kanghui Pharmaceutical's total shares, all of which were unrestricted circulating shares [1] - After the transfer, Sailuxian holds 3.9952 million shares, which is 4.00% of Kanghui Pharmaceutical's total shares, and remains as unrestricted circulating shares [1]